Cargando…
Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587194/ https://www.ncbi.nlm.nih.gov/pubmed/35499682 http://dx.doi.org/10.1007/s13311-022-01234-7 |
_version_ | 1784813851510833152 |
---|---|
author | Kim, Jeongah Park, Inah Jang, Sangwon Choi, Mijung Kim, Doyeon Sun, Woong Choe, Youngshik Choi, Ji-Woong Moon, Cheil Park, Sung Ho Choe, Han Kyoung Kim, Kyungjin |
author_facet | Kim, Jeongah Park, Inah Jang, Sangwon Choi, Mijung Kim, Doyeon Sun, Woong Choe, Youngshik Choi, Ji-Woong Moon, Cheil Park, Sung Ho Choe, Han Kyoung Kim, Kyungjin |
author_sort | Kim, Jeongah |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9587194 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-95871942022-11-29 Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease Kim, Jeongah Park, Inah Jang, Sangwon Choi, Mijung Kim, Doyeon Sun, Woong Choe, Youngshik Choi, Ji-Woong Moon, Cheil Park, Sung Ho Choe, Han Kyoung Kim, Kyungjin Neurotherapeutics Correction Springer International Publishing 2022-05-02 2022-07 /pmc/articles/PMC9587194/ /pubmed/35499682 http://dx.doi.org/10.1007/s13311-022-01234-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/. (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Correction Kim, Jeongah Park, Inah Jang, Sangwon Choi, Mijung Kim, Doyeon Sun, Woong Choe, Youngshik Choi, Ji-Woong Moon, Cheil Park, Sung Ho Choe, Han Kyoung Kim, Kyungjin Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease |
title | Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease |
title_full | Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease |
title_fullStr | Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease |
title_full_unstemmed | Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease |
title_short | Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease |
title_sort | correction to: pharmacological rescue with sr8278, a circadian nuclear receptor rev-erbα antagonist as a therapy for mood disorders in parkinson’s disease |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587194/ https://www.ncbi.nlm.nih.gov/pubmed/35499682 http://dx.doi.org/10.1007/s13311-022-01234-7 |
work_keys_str_mv | AT kimjeongah correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease AT parkinah correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease AT jangsangwon correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease AT choimijung correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease AT kimdoyeon correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease AT sunwoong correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease AT choeyoungshik correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease AT choijiwoong correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease AT mooncheil correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease AT parksungho correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease AT choehankyoung correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease AT kimkyungjin correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease |